Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
Go back to Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry| (NASDAQ: INBS) | Delayed: 2.36 +0.07 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.29 | 52 Week High | $ | |||
| Open | $2.35 | 52 Week Low | $ | |||
| Day High | $2.40 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $ | |||
| Volume | 9,342 | |||||
| (NASDAQ: INBS) | Delayed: 2.36 +0.07 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.29 | 52 Week High | $ | |||
| Open | $2.35 | 52 Week Low | $ | |||
| Day High | $2.40 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $ | |||
| Volume | 9,342 | |||||

